Akebia Therapeutics Inc. buy HC Wainwright
Start price
28.08.23
/
50%
€1.27
Target price
28.08.24
€3.47
Performance (%)
9.45%
End price
29.08.24
€1.39
Summary
This prediction ended on 29.08.24 with a price of €1.39. The BUY prediction by HC_Wainwright finished with a performance of 9.45%. HC_Wainwright has a follow-up prediction for Akebia Therapeutics Inc. where he still thinks Akebia Therapeutics Inc. is a Buy. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | 1.958% | 1.958% | -65.146% |
| iShares Core DAX® | 3.153% | 1.504% | 9.129% |
| iShares Nasdaq 100 | 7.431% | -1.584% | 28.642% |
| iShares Nikkei 225® | 8.571% | -4.324% | 53.026% |
| iShares S&P 500 | 4.578% | 1.920% | 23.965% |
Comments by HC_Wainwright for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $3.75 price target on the stock.
Ratings data for AKBA provided by MarketBeat
In the thread Trading Akebia Therapeutics Inc.
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten
Current prediction by HC_Wainwright for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
02.12.25
02.12.25
€5.17
02.12.26
02.12.26
-12.26%
05.08.26
05.08.26
Stopped prediction by HC_Wainwright for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.07
01.07.26
01.07.26
€5.26
01.07.27
01.07.27
3.87%
05.08.26
05.08.26
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.12
04.06.25
04.06.25
€7.03
04.06.26
04.06.26
-73.92%
05.06.26
05.06.26
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.61
04.04.25
04.04.25
€6.78
04.04.26
04.04.26
-30.81%
05.04.26
05.04.26
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.92
14.03.25
14.03.25
€6.91
14.03.26
14.03.26
-32.39%
15.03.26
15.03.26
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.30
23.01.25
23.01.25
€7.19
23.01.26
23.01.26
-50.74%
24.01.26
24.01.26
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.82
14.01.25
14.01.25
€7.29
14.01.26
14.01.26
-36.30%
15.01.26
15.01.26
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.53
23.10.24
23.10.24
€6.96
23.10.25
23.10.25
63.81%
24.10.25
24.10.25
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.19
08.10.24
08.10.24
€6.83
08.10.25
08.10.25
101.51%
09.10.25
09.10.25
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.26
06.09.24
06.09.24
€6.74
06.09.25
06.09.25
95.40%
07.09.25
07.09.25
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.82
28.03.24
28.03.24
€5.55
28.03.25
28.03.25
-5.70%
29.03.25
29.03.25
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.92
17.11.23
17.11.23
€4.60
17.11.24
17.11.24
81.13%
18.11.24
18.11.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.11
27.09.23
27.09.23
€3.55
27.09.24
27.09.24
2.70%
28.09.24
28.09.24